僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Ficlatuzumab is a monoclonal antibody （McAb） targeting human hepatocyte growth factor （HGF）. Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion